Form 4 for ABEO ABEONA THERAPEUTICS INC.
Accepted 2022-10-18 00:00:00 ET · period of report 2022-10-17 · accession 0001493152-22-028650 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-18 | 2022-10-17 | ABEO | Seshadri Vishwas | CEO, Dir | F - Tax | $4.30 | -207 | 165.7K | -0.1% | -$890.10 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-17 | F | D | 207 | $4.30 | 165,732 | D | — | — | (F1) Represents the number of shares that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock and does not represent a sale. |